BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Antar W, El-Shokry MH, Abd El Hamid WA, Helmy MF. Significance of detecting anti-HBc among Egyptian male blood donors negative for HBsAg. Transfus Med. 2010;20:409-413. [PMID: 20573069 DOI: 10.1111/j.1365-3148.2010.01021.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Stolz M, Tinguely C, Fontana S, Niederhauser C. Hepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors: Sensitivity Limit for HBV DNA in Blood Donors. Transfusion 2014;54:2961-7. [DOI: 10.1111/trf.12694] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
2 Mahmoud RA, El-Mazary AA, Khodeary A. Seroprevalence of Hepatitis C, Hepatitis B, Cytomegalovirus, and Human Immunodeficiency Viruses in Multitransfused Thalassemic Children in Upper Egypt. Adv Hematol 2016;2016:9032627. [PMID: 26989417 DOI: 10.1155/2016/9032627] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
3 Ye X, Li T, Xu X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China. Blood Transfus 2017;15:6-12. [PMID: 27416568 DOI: 10.2450/2016.0268-15] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
4 Elmaghloub R, Elbahrawy A, Didamony GE, Elwassief A, Saied Mohammad AG, Alashker A, Zedan H, Abdallah AM, Hemidah MH, Elmestikawy A, Fayoumei ME, Shahba H, Gawish A, Morsy MH, Hashim A, Abdelbaseer MA, Ueda Y, Chiba T, Abdelhafeez H. Hepatitis B Virus Genotype E Infection among Egyptian Health Care Workers. J Transl Int Med 2017;5:100-5. [PMID: 28721342 DOI: 10.1515/jtim-2017-0012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
5 Allain J, Opare-sem O. Screening and diagnosis of HBV in low-income and middle-income countries. Nat Rev Gastroenterol Hepatol 2016;13:643-53. [DOI: 10.1038/nrgastro.2016.138] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
6 Muselmani W, Habbal W, Monem F. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors. Transfus Med 2013;23:265-8. [PMID: 23621787 DOI: 10.1111/tme.12043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Mortensen E, Kamali A, Schirmer PL, Lucero-Obusan C, Winston CA, Oda G, Winters MA, Durfee J, Martinello RA, Davey VJ, Holodniy M. Are current screening protocols for chronic hepatitis B virus infection adequate? Diagn Microbiol Infect Dis 2016;85:159-67. [PMID: 27009896 DOI: 10.1016/j.diagmicrobio.2015.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
8 Kupek E. Residual Risk of Hepatitis-B-Infected Blood Donations: Estimation Methods and Perspectives. ISRN Infectious Diseases 2013;2013:1-15. [DOI: 10.5402/2013/839896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Allain JP, Cox L. Challenges in hepatitis B detection among blood donors. Curr Opin Hematol 2011;18:461-6. [PMID: 21912252 DOI: 10.1097/MOH.0b013e32834bac10] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
10 Wu T, Kwok RM, Tran TT. Isolated anti-HBc: The Relevance of Hepatitis B Core Antibody-A Review of New Issues. Am J Gastroenterol 2017;112:1780-8. [PMID: 29087395 DOI: 10.1038/ajg.2017.397] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
11 Hussein E. Blood donor recruitment strategies and their impact on blood safety in Egypt. Transfus Apher Sci 2014;50:63-7. [PMID: 24325889 DOI: 10.1016/j.transci.2013.11.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
12 Elbahrawy A, Alaboudy A, El Moghazy W, Elwassief A, Alashker A, Abdallah AM. Occult hepatitis B virus infection in Egypt. World J Hepatol 2015; 7(12): 1671-1678 [PMID: 26140086 DOI: 10.4254/wjh.v7.i12.1671] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
13 Shastry S, Bhat SS. Prevention of post-transfusion hepatitis by screening of antibody to hepatitis B core antigen in healthy blood donors. Mediterr J Hematol Infect Dis 2011;3:e2011062. [PMID: 22220259 DOI: 10.4084/MJHID.2011.062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
14 El-Nabi SH, El-Garawani I, Ismail F, Abdelsameea E. Anti-HBc and hepatitis B virus DNA among HBsAg-negative blood donors from the main central blood bank units in Eastern Libya. Transfus Med 2020;30:401-5. [PMID: 32894893 DOI: 10.1111/tme.12711] [Reference Citation Analysis]
15 Said ZN, Sayed MHE, Salama II, Aboel-Magd EK, Mahmoud MH, Setouhy ME, Mouftah F, Azzab MB, Goubran H, Bassili A, Esmat GE. Occult hepatitis B virus infection among Egyptian blood donors. World J Hepatol 2013; 5(2): 64-73 [PMID: 23646231 DOI: 10.4254/wjh.v5.i2.64] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
16 Niederhauser C. Reducing the risk of hepatitis B virus transfusion-transmitted infection. J Blood Med 2011;2:91-102. [PMID: 22287868 DOI: 10.2147/JBM.S12899] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
17 Fopa D, Candotti D, Tagny CT, Doux C, Mbanya D, Murphy EL, Kenawy HI, El Chenawi F, Laperche S. Occult hepatitis B infection among blood donors from Yaoundé, Cameroon. Blood Transfus 2019;17:403-8. [PMID: 31846605 DOI: 10.2450/2019.0182-19] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Diarra B, Yonli AT, Sorgho PA, Compaore TR, Ouattara AK, Zongo WA, Tao I, Traore L, Soubeiga ST, Djigma FW. Occult Hepatitis B Virus Infection and Associated Genotypes among HBsAg-negative Subjects in Burkina Faso. Mediterr J Hematol Infect Dis. 2018;10:e2018007. [PMID: 29326804 DOI: 10.4084/mjhid.2018.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
19 Ayana DA, Mulu A, Mihret A, Seyoum B, Aseffa A, Howe R. Occult Hepatitis B virus infection among HIV negative and positive isolated anti-HBc individuals in eastern Ethiopia. Sci Rep 2020;10:22182. [PMID: 33335238 DOI: 10.1038/s41598-020-79392-x] [Reference Citation Analysis]
20 Pondé RA. Molecular mechanisms underlying HBsAg negativity in occult HBV infection. Eur J Clin Microbiol Infect Dis. 2015;34:1709-1731. [PMID: 26105620 DOI: 10.1007/s10096-015-2422-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
21 Izmirli S, Celik DG, Yuksel P, Saribas S, Aslan M, Ergin S, Bahar H, Sen S, Cakal B, Oner A. The detection of occult HBV infection in patients with HBsAg negative pattern by real-time PCR method. Transfus Apher Sci. 2012;47:283-287. [PMID: 23021041 DOI: 10.1016/j.transci.2012.07.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
22 Velati C, Fomiatti L, Baruffi L, Piccinini V, Prati D, Reina A, Lobbiani A, Zanetti A, Romanò L. Criteria for hepatitis B virus screening and validation of blood components in Italy: the position of the SIMTI HBV working group. Blood Transfus 2011;9:455-61. [PMID: 21839007 DOI: 10.2450/2011.0014-11] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
23 El-Ghitany EM, Farghaly AG. Evaluation of commercialized rapid diagnostic testing for some Hepatitis B biomarkers in an area of intermediate endemicity. J Virol Methods. 2013;194:190-193. [PMID: 24004823 DOI: 10.1016/j.jviromet.2013.08.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
24 Oluyinka OO, Tong HV, Bui Tien S, Fagbami AH, Adekanle O, Ojurongbe O, Bock CT, Kremsner PG, Velavan TP. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks. PLoS One. 2016;10:e0131912. [PMID: 26148052 DOI: 10.1371/journal.pone.0131912] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
25 Akinbami AA, Oshinaike OO, Dosunmu OA, Adeyemo TA, Adediran A, Akanmu S, Wright KO, Ilori S, Aile K. Seroprevalence of hepatitis B e antigen (HBe antigen) and B core antibodies (IgG anti-HBcore and IgM anti-HBcore) among hepatitis B surface antigen positive blood donors at a Tertiary Centre in Nigeria. BMC Res Notes 2012;5:167. [PMID: 22455501 DOI: 10.1186/1756-0500-5-167] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
26 Sarah YAEGA, Sabry AEGAEHES, Maryam AA. Seropositivity of TTIs among blood donors in Hail, Saudi Arabia, from 2014 to 2015. Asian Pacific Journal of Tropical Disease 2016;6:141-6. [DOI: 10.1016/s2222-1808(15)61000-3] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]